| Issue Date | Title | Author(s) |
| 2012-09-06 | CD86<sup>+</sup>or HLA-G<sup>+</sup> can be transferred via trogocytosis from myeloma cells to T cells and are associated with poor prognosis | Brown, R; Kabani, K; Favaloro, J; Yang, S; Ho, PJ; Gibson, J; Fromm, P; Suen, H; Woodland, N; Nassif, N; Hart, D; Joshua, D |
| 2020-10 | Inverse relationship between oligoclonal expanded CD69- TTE and CD69+ TTE cells in bone marrow of multiple myeloma patients. | Vuckovic, S; Bryant, CE; Lau, KHA; Yang, S; Favaloro, J; McGuire, HM; Clark, G; de St Groth, BF; Marsh-Wakefield, F; Nassif, N; Abadir, E; Vanguru, V; McCulloch, D; Brown, C; Larsen, S; Dunkley, S; Khoo, L; Gibson, J; Boyle, R; Joshua, D; Ho, PJ |
| 2013-09-01 | Long-term survival in multiple myeloma is associated with a distinct immunological profile, which includes proliferative cytotoxic T-cell clones and a favourable Treg/Th17 balance | Bryant, C; Suen, H; Brown, R; Yang, S; Favaloro, J; Aklilu, E; Gibson, J; Ho, PJ; Iland, H; Fromm, P; Woodland, N; Nassif, N; Hart, D; Joshua, DE |
| 2013 | Long-term survival in multiple myeloma is associated with a distinct immunological profile, which includes proliferative cytotoxic T-cell clones and a favourable Treg/Th17 balance | Bryant, C; Suen, H; Brown, R; Yang, S; Favaloro, J; Aklilu, E; Gibson, J; Ho, P; Iland, H; Fromm, P; Woodland, N; Nassif, N; Hart, D; Joshua, D |
| 2014-01-01 | Myeloid derived suppressor cells are numerically, functionally and phenotypically different in patients with multiple myeloma | Favaloro, J; Liyadipitiya, T; Brown, R; Yang, S; Suen, H; Woodland, N; Nassif, N; Hart, D; Fromm, P; Weatherburn, C; Gibson, J; Ho, PJ; Joshua, D |
| 2022-08 | OAB-023: Single-cell analysis reveals disease induced perturbations of CD8+T-cell subsets in the bone marrow and peripheral blood of newly diagnosed multiple myeloma patients | Favaloro, J; Bryant, C; Abadir, E; Yang, S; Gardiner, S; Nassif, N; Sedger, L; Joshua, D; Ho, PJ |
| 2023-10-05 | Single cell analysis of the CD8+ T-cell compartment in multiple myeloma reveals disease specific changes are chiefly restricted to a CD69- subset suggesting potent cytotoxic effectors exist within the tumor bed. | Favaloro, J; Bryant, CE; Abadir, E; Gardiner, S; Yang, S; King, T; Nassif, N; Sedger, LM; Boyle, R; Joshua, DE; Ho, PJ |
| 2021-02-23 | Treg and Oligoclonal Expansion of Terminal Effector CD8+ T Cell as Key Players in Multiple Myeloma | Joshua, DE; Vuckovic, S; Favaloro, J; Lau, KHA; Yang, S; Bryant, CE; Gibson, J; Ho, PJ |
